GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (STU:47M) » Definitions » Purchase Of Investment

MedMira (STU:47M) Purchase Of Investment : €-0.00 Mil (TTM As of Jul. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MedMira Purchase Of Investment?

MedMira's purchase of investment for the three months ended in Jul. 2024 was €0.00 Mil. It means MedMira spent €0.00 Mil on purchasing investments. MedMira's purchase of investment for the trailing twelve months (TTM) ended in Jul. 2024 was €-0.00 Mil.

Compared with last quarter (€0.00 Mil in Apr. 2024 ), MedMira spent the same money on purchasing investments in Jul. 2024 (€0.00 Mil).

MedMira Purchase Of Investment Historical Data

The historical data trend for MedMira's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Purchase Of Investment Chart

MedMira Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedMira Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MedMira Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of MedMira's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (STU:47M) » Definitions » Purchase Of Investment
Comparable Companies
TSXV:NRX TSX:MBX XCNQ:GLAB TSX:HBP TSX:BCT XCNQ:DOSE TSX:SVA TSXV:TTI XCNQ:MDMA TSX:TH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
MMIRF:USA 47M:Germany MIR:Canada
Address
155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
Website
https://www.medmira.com
MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

MedMira Headlines

No Headlines